Financhill
Back

TG Therapeutics, Inc. Stock Predictions

TG Therapeutics, Inc. Stock Forecast

  • Over the next 52 weeks, TG Therapeutics, Inc. has on average historically risen by 20.7% based on the past 30 years of stock performance.
  • TG Therapeutics, Inc. has risen higher in 14 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.67%
  • Is TG Therapeutics, Inc. Stock Undervalued?
    The current TG Therapeutics, Inc. [TGTX] share price is $30.57. The Score for TGTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • TGTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will TG Therapeutics, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, TG Therapeutics, Inc. has on average historically risen by 20.7% based on the past 30 years of stock performance.

TG Therapeutics, Inc. Stock Rating

Sell
49
TG Therapeutics, Inc. (TGTX) is a Sell

Is TG Therapeutics, Inc. overpriced?

  • TG Therapeutics, Inc. has risen higher in 14 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.67%

TG Therapeutics, Inc. Stock Price History

Is TGTX stock going to rise?

  • The current trend is relatively stagnant and TGTX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tgtherapeutics.com

52-Week Data

52-Week High:
46.48
52-Week Low:
25.28

Prediction Charts

Market Cap:
4.9B
Price in USD:
30.57
Volume:
2.5M
Beta:
0.92

Technical Analysis

SMA50:
30.88
SMA100:
32.26
SMA200:
33.97
52-Wk Change:
4.91%

Stock Predictions

  • Is TG Therapeutics, Inc. stock public?
    Yes, TG Therapeutics, Inc. is a publicly traded company.
  • What is the TG Therapeutics, Inc. stock quote today?
    The TG Therapeutics, Inc. stock price is 30.57 USD today.
  • How to buy TG Therapeutics, Inc. stock online?
    You can buy TG Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-29 30.77 30.53 30.88 30.43
Dec-30 30.44 29.75 30.56 29.69
Dec-31 29.70 29.81 30.15 29.51
Jan-2 29.56 29.28 29.95 28.82
Jan-5 28.98 29.90 29.92 28.98
Jan-6 29.76 29.41 29.91 28.90
Jan-7 29.84 30.34 30.63 29.41
Jan-8 30.10 30.50 30.64 29.57
Jan-9 30.70 28.47 30.90 28.21
Jan-12 28.31 27.72 28.44 27.35
Jan-13 27.65 27.87 28.91 26.89
Jan-14 31.16 29.54 33.24 28.45
Jan-15 29.54 30.71 32.03 29.09
Jan-16 30.99 30.57 31.25 30.30

TG Therapeutics, Inc. Earnings

TG Therapeutics, Inc. Earnings Report: Per Share TG Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

TG Therapeutics, Inc. Forecast Revenue Growth

TG Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for TG Therapeutics, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.22 per share, and an increase next year of $0.74 per share.

* TG Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.